TY - JOUR
T1 - PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells
AU - Eliasson, Lena
AU - Renström, Erik
AU - Ammala, Carina
AU - Berggren, Per-Olof
AU - Bertorello, Alejandro M.
AU - Bokvist, Krister
AU - Chibalin, Alexander
AU - Deeney, Jude T.
AU - Flatt, Peter R.
AU - Gabel, Jakob
AU - Gromada, Jesper
AU - Larsson, Olof
AU - Lindstrom, Per
AU - Rhodes, Christopher J.
AU - Rorsman, Patrik
PY - 1996
Y1 - 1996
N2 - Hypoglycemic sulfonylureas represent a group of clinically useful antidiabetic compounds that stimulate insulin secretion from pancreatic beta cells. The molecular mechanisms involved are not fully understood but are believed to involve inhibition of potassium channels sensitive to adenosine triphosphate (KATP channels) in the beta cell membrane, causing membrane depolarization, calcium influx, and activation of the secretory machinery. In addition to these effects, sulfonylureas also promoted exocytosis by direct interaction with the secretory machinery not involving closure of the plasma membrane KATP channels. This effect was dependent on protein kinase C (PKC) and was observed at therapeutic concentrations of sulfonylureas, which suggests that it contributes to their hypoglycemic action in diabetics.
AB - Hypoglycemic sulfonylureas represent a group of clinically useful antidiabetic compounds that stimulate insulin secretion from pancreatic beta cells. The molecular mechanisms involved are not fully understood but are believed to involve inhibition of potassium channels sensitive to adenosine triphosphate (KATP channels) in the beta cell membrane, causing membrane depolarization, calcium influx, and activation of the secretory machinery. In addition to these effects, sulfonylureas also promoted exocytosis by direct interaction with the secretory machinery not involving closure of the plasma membrane KATP channels. This effect was dependent on protein kinase C (PKC) and was observed at therapeutic concentrations of sulfonylureas, which suggests that it contributes to their hypoglycemic action in diabetics.
U2 - 10.1126/science.271.5250.813
DO - 10.1126/science.271.5250.813
M3 - Article
VL - 271
SP - 813
EP - 815
JO - Science (New York, N.Y.)
JF - Science (New York, N.Y.)
SN - 1095-9203
IS - 5250
ER -